Conflicts of interest – Charles Nemeroff take a bow!

As you all know, Charles ‘Chuck’ Nemeroff, the controversial former Emory University psychiatry department chair, has been named chair of the psychiatry department at the University of Miami School of Medicine. [My Nemeroff back catalogue is  here, here and here. Read even more here, here and here.]

It was only October last year that Chuck was forced to resign from Brown University.

The Miami Herald reported:

“On Thursday, Pascal Goldschmidt, dean of UM medical school, called Nemeroff ‘an extraordinary psychiatrist and scientist. . . . He got into serious trouble on disclosure on conflict of interest.’ “Goldschmidt said he had read investigative reports from Emory about Nemeroff’s activities and found nothing to indicate that payments the psychiatrist received had in any way influenced his research results.

Check out this list of some of Chuck’s ‘activities’ from CL Pysch

Pharmaceutical and Clinical Research Company Scientific Advisory Boards

Abbott Laboratories
– Consultant, Abbott Laboratories, Diagnostics Division, 1986-1992.
– Research and Education Advisory Board for Psychiatry
– Member, 1990 – 2006
– Executive Board, 1991 – 1993, 2003 – 2006
-Antidepressant Advisory Board, 1991 – 1992

ACADIA Pharmaceuticals Clinical Advisory Board
– Member, 2000 – 2006.

AstraZeneca Pharmaceuticals
– Psychiatry Advisory Board, 1997 – 2001.
– Chairman, 1999 – 2002.
– Neuroscience Scientific Advisory Board, 1999 – present.

Bristol-Myers-Squibb
– Antipsychotic Advisory Board, 2003 – 2006.
– Antidepressant Advisory Board, 2003 – 2006.
– EMSAM Advisory Board – Chairman, 2005-2006.

Cephalon Pharmaceuticals
– Scientific Advisory Board, 2002

Comprehensive Neuroscience, Inc.
– Scientific Advisory Board, 1999 – 2004.

Corcept
– Scientific Advisory Board, 2001 – 2006

Cyberonics
– Scientific Advisory Board, 2002 – 2006.
– Chair, Mechanism of Action Board, 2003 – 2006.

Cypress Biosciences, Inc.
– Board of Directors, 2001 – 2004
– Consultant, 2004 – 2006

Eli Lilly and Company
– Psychiatry Advisory Board, 1990 – 2000.
– Bipolar Advisory Board, 1998 – 1999.
– Consultant, 2002 – 2003.
– Global Neuroscience Advisory Board, 2005 – 2006.

Forest Laboratories
– Citalopram Clinical Advisory Board, 1997 – 2002.
– Psychiatry Scientific Advisory Board, Chairman, 1999 – 2008.

GlaxoSmithKline Advisory Board of Psychiatrists
– Chairman, 1991 – 2004.

Janssen Pharmaceuticals
– Mood Disorders Advisory Board, Member and Chairman, 1998 – 2004.
– Topiramate Advisory Board, Member and Chairman, 1999 – 2001.
– Antipsychotic Advisory Board, Member, 1999 – present.

Johnson & Johnson Scientific Advisory Board, 2007- present.

Lundbeck
– Consultant, 2006

Merck Sharp & Dohme Research Laboratories
– Consultant, Neuroscience Research Center, 1994.
– Mood Disorders Advisory Board, 1999 – 2003.

Merck-MedCo Mental Health Advisory Board
– Member, 1996 – 1998

Mt. Cook Pharma
– Board of Directors, 2007 – Present

Neurocrine Biosciences
– Scientific Advisory Board, 1994 – 2004.

Neuronetics
– Scientific Advisory Board, 2006

Novadel Pharma
– Board of Directors, 2003 – present
– Chair, Scientific Advisory Committee
– Member, Compensation Committee
– Member, Nominating Committee

Novartis Pharmaceutical Company
– Bipolar Advisory Board Chairman, 2001 – 2003.
– Pediatric Bipolar Advisory Board, 2002 – 2003.
– Antidepressant Advisory Board, 2006.

Organon Pharmaceuticals Psychiatry Advisory Board
– Member, 1997 – 2004.

Otsuka Psychiatry Advisory Board
– Chairman, 2003 – 2006.

PharmaNeuroboost
– Scientific Advisory Board, 2006 – present.

Pfizer Pharmaceuticals
– Clinical Neuroscience Advisory Board, 2004 – 2006.
– Chair, Antipsychotic Advisory Board, 2004 – 2006.

Quintiles Scientific Advisory Board, 2004 – present

Revaax
– Stockholder

Roche Laboratories, a Division of Hoffman-LaRoche, Inc.
– Mania Advisory Board, 1993.
– Pharmocogenomics Advisory Board, 2006

Sanofi/Synthelabo
– Psychiatry Advisory Board, 2002 – 2005.

SciRex
– Scientific Advisory Board, 1999 – 2003.

Solvay Pharmaceuticals Psychiatry Advisory Board
– Member, 1991 – 1999.
– Chairman, 1991 – 1999.
– Antipsychotic Advisory Board, 2005 – 2006.

Somerset Pharmaceuticals Psychiatry Advisory Board
– Chair, 2000 – 2004.

Vela Pharmaceuticals
– Scientific Advisory Board, 2001 – 2002.

Wyeth-Ayerst Psychiatric Advisory Board
– Chairman and Member, 1995 – 2002.

2 Responses to “Conflicts of interest – Charles Nemeroff take a bow!”

  1. truthman30 Says:

    And of course Mr. Nemeroff did all this massively lucrative amount of pharmaceutical industry work for the good of psychiatric patients and the well being of the mentally ill? .. And also of course it was not in the interest of his own self deluded psychiatrst ego?..

  2. Nancy E. Bowling Says:

    My sister almost lost her life because of the ‘good’ Nemeroff did for mankind. She had a Cyberonics Vns device implanted to treat a seizure disorder, and had to be put on life support twice, was hospitalized for almost an entire year, and now if permanetly disabled because of it. I do not understand why this man is not in jail. Why hasn’t he been charged with any crimes? Why is he allowed to be walking free, while so many of his victims are laying beneath 6 feet of dirt? Our country needs to get their priorities straight, and just because you have a ‘name’ and wear expensive tailored suits, doesn’t mean you should be able to get by with murder. This man is a complete disgrace to the medical community and to the human race as a whole, for that matter. Just the sound of his name makes me want to vomit.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: